Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 2, 2003, Pages 315-326

  Reeves, Ruth ^a   Thiruchelvam, Mona ^a   Richfield, Eric K ^a   Cory Slechta, Deborah A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Behavioral sensitization; Neurotoxicity; Pesticides; Triadimefon

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; FUNGICIDE; TRIADIMEFON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PSYCHOSIS; RECEPTOR BINDING; SENSITIZATION;

EID: 0142226999     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.08.003     Document Type: Article

References (55)

1. Allen A.R., MacPhail R.C. Effects of triadimefon on a multiple schedule of fixed-interval performance: comparison with methylphenidate, D-amphetamine and chlorpromazine. Pharmacol. Biochem. Behav. 40:1991;775-780.
2. Burger L.Y., Martin-Iverson M.T. Increased occupation of D1 and D2 dopamine receptors accompanies cocaine-induced behavioral sensitization. Brain Res. 639:1994;228-232.
3. Cador M., Bjijou Y., Cailhol S., Stinus L. D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience. 94:1999;705-721.
4. Capper-Loup C., Canales J.J., Kadaba N., Graybiel A.M. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J. Neurosci. 22:2002;6218-6227.
5. Chin J., Sternin O., Wu H.B., Burrell S., Lu D., Jenab S.et al. Endogenous gonadal hormones modulate behavioral and neurochemical responses to acute and chronic cocaine administration. Brain Res. 945:2002;123-130.
6. Cornish J.L., Nakamura M., Kalivas P.W. Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area. J. Pharmacol. Exp. Ther. 298:2001;226-233.
7. Crippens D., Camp D.M., Robinson T.E. Basal extracellular dopamine in the nucleus accumbens during amphetamine withdrawal: a 'no net flux' microdialysis study. Neurosci. Lett. 164:1993;145-148.
8. Crofton K.M., Boncek V.M., Reiter L.W. Hyperactivity induced by triadimefon, a triazole fungicide. Fundam. Appl. Toxicol. 10:1988;459-465.
9. Crofton K.M., Boncek V.M., MacPhail R.C. Evidence for monoaminergic involvement in triadimefon-induced hyperactivity. Psychopharmacology. 97:1989;326-330.
10. Druhan J.P., Wilent W.B. Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization induced by cocaine. Behav. Brain Res. 102:1999;195-210.
11. Farfel G.M., Kleven M.S., Woolverton W.L., Seiden L.S., Perry B.D. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 578:1992;235-243.
12. Franklin K.B.J., Paxinos G. The mouse brain, in stereotaxic coordinates. 1997;Academic Press, San Diego.
13. Henry D.J., White F.J. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neurosci. 15:1995;6287-6299.
14. Henry D.J., Hu X.T., White F.J. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology (Berl.). 140:1998;233-242.
15. Hill D., Ikaiddi M., Mazzio E., Soliman K.F. The neurochemical basis for the behavioral effects of triadimefon. Ann. N.Y. Acad. Sci. 914:2000;336-353.
16. Hoffman D.C., Beninger R.J. The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats. Pharmacol. Biochem. Behav. 22:1985;341-342.
17. Ikaiddi M.U., Akunne H.C., Soliman K.F.A. Behavioral and neurochemical effects of acute and repeated administration of triadimefon in the male rat. Neurotoxicology. 18:1997;771-780.
18. Kalivas P.W., Duffy P. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J. Pharmacol. Exp. Ther. 241:1987;204-212.
19. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine: I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
20. Kalivas P.W., Sorg B.A., Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4:1993;315-334.
21. Karler R., Calder L.D., Bedingfield J.B. A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice. Brain Res. 725:1996;192-198.
22. Kleven M.S., Perry B.D., Woolverton W.L., Seiden L.S. Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Res. 532:1990;265-270.
23. Li Y., Vartanian A.J., White F.J., Xue C.J., Wolf M.E. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology (Berl.). 134:1997;266-276.
24. MacPhail R.C., Farmer J.D., Chu T.H., Walker Q.D. Dopaminergic participation in triadimefon-induced hyperactivity. Abstr. - Soc. Neurosci. 1993;19.
25. Mayfield R.D., Larson G., Zahniser N.R. Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res. 573:1992;331-335.
26. Meil W.M., Roll J.M., Grimm J.W., Lynch A.M., See R.E. Tolerance-like attenuation to contingent and noncontingent cocaine-induced elevation of extracellular dopamine in the ventral striatum following 7 days of withdrawal from chronic treatment. Psychopharmacology (Berl.). 118:1995;338-346.
27. Meyer M.E., Shults J.M. Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats. Pharmacol. Biochem. Behav. 46:1993;269-274.
28. Moser V.C., MacPhail R.C. Neurobehavioral effects of triadimefon, a triazole fungicide, in male and female rats. Neurotoxicol. Teratol. 11:1989;285-293.
29. Moser V.C., MacPhail R.C. Comparative sensitivity of neurobehavioral tests for chemical screening. Neurotoxicology. 11:1990;335-344.
30. Nestler E.J., Hope B.T., Widnell K.L. Drug addiction: a model for the molecular basis of neural plasticity. Neuron. 11:1993;995-1006.
31. Nishikawa T., Mataga N., Takashima M., Toru M. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur. J. Pharmacol. 88:1983;195-203.
32. Ohmori T.T., Abekawa T.T., Koyama T.T. Environment modifies the expression of behavioral sensitization produced by methamphetamine: behavioral and neurochemical studies. Behav. Pharmacol. 6:1995;133-142.
33. Peris J., Boyson S.J., Cass W.A., Curella P., Dwoskin L.P., Larson G.et al. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253:1990;38-44.
34. Perkins A.N., Eckerman D.A., MacPhail R.C. Discriminative stimulus properties of triadimefon: comparisons with methylphenidate. Pharmacol. Biochem. Behav. 40:1991;757-761.
35. Pierce R.C., Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275:1995;1019-1029.
36. Pierce R.C., Bell K., Duffy P., Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16:1996;1550-1560.
37. Pierce R.C., Reeder D.C., Hicks J., Morgan Z.R., Kalivas P.W. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience. 82:1998;1103-1114.
38. Pilotte N.S., Sharpe L.G., Rountree S.D., Kuhar M.J. Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens. Synapse. 22:1996;87-92.
39. Post R.M., Lockfeld A., Squillace K.M., Contel N.R. Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci. 28:1981;755-760.
40. Reeves R, Thiruchelvam M, Baggs, RB, Cory-Slechta DA. Interactions of paraquat and triadimefon: behavioral and neurochemical effects. Neurotoxicology [in press].
41. Richfield E.K., Young A.B., Penney J.B. Comparative distributions of dopamine D-1 and D-2 receptors in the cerebral cortex of rats, cats, and monkeys. J. Comp. Neurol. 286:1989;409-426.
42. RTEC Tatken R.L., Lewis R.J. Registry of toxic effects of chemical substances. 1983;. NIOSH, D.H.H.S.
43. Segal D.S., Mandell A.J. Long-term administration of D-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2:1974;249-255.
44. 3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 203:1991;141-144.
45. Shilling P.D., Kelsoe J.R., Segal D.S. Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci. Lett. 236:1997;131-134.
46. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 86:1989;1398-1400.
47. Thiruchelvam M., Richfield E.K., Baggs R.B., Tank A.W., Cory-Slechta D.A. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20:2000;9207-9214.
48. Tzschentke T.M., Schmidt W.J. The development of cocaine-induced behavioral sensitization is affected by discrete quinolinic acid lesions of the prelimbic medial prefrontal cortex. Brain Res. 795:1998;71-76.
49. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605:1993;332-337.
50. Walker Q.D., Mailman R.B. Triadimefon and triadimenol: effects on monoamine uptake and release. Toxicol. Appl. Pharmacol. 139:1996;227-233.
51. Walker Q.D., Lewis M.H., Crofton K.M., Mailman R.B. Triadimefon, a triazole fungicide, induces stereotyped behavior and alters monoamine metabolism in rats. Toxicol. Appl. Pharmacol. 102:1990;474-485.
52. Wallace T.L., Gudelsky G.A., Vorhees C.V. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat. Synapse. 39:2001;1-7.
53. Winter C.K., Kurtz P.H. Factors influencing grape worker susceptibility to skin rashes. Bull. Environ. Contam. Toxicol. 35:1985;418-426.
54. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264:1993;249-255.
55. Wolf M.E., Dahlin S.L., Hu X.-T., Xue C.-J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.